Several forms of human tumors involve the abnormal cAMP-PKA-CREB signaling pathway (such as breast, colorectal, ovarian, and hypophysis) through enhancing tumor cell growth, invasion, migration, and metabolism; consequently, targeting this pathway can be a good option for cancer treatment (52, 55-58). The gene discussed is CREB1; the disease is neoplasm.